<b>Canagliflozin-induced adaptive metabolism in bone</b> حسب Sher Bahadur Poudel (20686192)

"…CANA-treated male mice exhibited notable reductions in body weight and decreased proinflammatory and bone remodeling markers associated with reduced cortical bone remodeling indices. …"

Table 8_Effect of natural bioactive compounds on growth and welfare in Octopus vulgaris paralarvae.xlsx حسب M. Virginia Martín (6321047)

"…Although enzymatic antioxidant responses such as catalase (CAT) and superoxide dismutase (SOD) were unaffected, glutathione S-transferase (GST) activity significantly decreased in the BCO group, suggesting a reduced need for detoxification due to lower oxidative stress. …"

Supplementary file 6_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx حسب Yi-Chang Zhao (14080107)

"…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …"

Table 1_Effect of natural bioactive compounds on growth and welfare in Octopus vulgaris paralarvae.xlsx حسب M. Virginia Martín (6321047)

"…Although enzymatic antioxidant responses such as catalase (CAT) and superoxide dismutase (SOD) were unaffected, glutathione S-transferase (GST) activity significantly decreased in the BCO group, suggesting a reduced need for detoxification due to lower oxidative stress. …"

Additional file 1 of Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes حسب Kristel S. Knudsen (10535406)

"…Every red dot on the plot represents differentially abundant species with increased significance noted towards the top of the plot. Grey dot: not significant…"

Supplemental Materials for "<b>Bilaterality is an Independent Risk Factor for Recurrence in </b><b><i>BRAF</i></b><b>-mutant P</b><b>apillary T</b><b>hyroid Cancer</b>" حسب Shitu Chen (20472071)

"…The <i>BRAF</i> mutation status was confirmed by Sanger sequencing. The cases were analyzed for various histologic and clinical parameters in order to determine correlation between bilaterality and risk of recurrence in the different <i>BRAF</i> status.…"

DMSO induces a reduction in somite’s size. حسب Geyse Gomes (22075629)

"…Somites’ thickness significantly decreases after treatment with 2%, 3% and 4% DMSO (D). ns = non-significant. …"

Supplementary file 1_The efficacy and safety of endoscopic surgery combined with platelet-rich plasma for lumbar disk herniation: a systematic review and meta-analysis.pdf حسب Guimei Guo (4127074)

"…For back pain, VAS scores decreased significantly at 3 months (MD = −0.58, 95% CI: −0.84 to −0.31, p < 0.0001), 6 months (MD = −0.32, 95% CI: −0.48 to −0.16, p = 0.0001), ≥12 months (MD = −0.40, 95% CI: −0.51 to −0.28, p < 0.00001) and at last follow-up (MD = −0.23, 95% CI: −0.36 to −0.10, p = 0.0005; very low certainty). …"

Supplementary file 1_The impact of SGLT2 inhibitors on cardiac remodeling after myocardial infarction: an updated meta-analysis of randomized controlled trials.zip حسب Ma Li Xu (21163796)

"…There were decreases in LVESVI, LVEDVI, LVEDD, LVESD, LVESV, and LVEDV. …"

GABA and glutamate are required for light avoidance. حسب Kenichi Nakayama (2354653)

"…<i>Ppa-unc-25</i> and <i>Ppa-eat-4</i> mutants exhibit decreased light avoidance. One-way ANOVA Dunnett’s multiple comparison tests, compared with wild type. n.s = not significant, *<i>P</i> < 0.05, ****<i>P</i> < 0.0001.…"

Additional file 2 of Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes حسب Kristel S. Knudsen (10535406)

"…Every red dot on the plot represents differentially abundant species with increased significance noted towards the top of the plot. Grey dot: not significant…"

Elevated serum sFlt-1 at 18–20 weeks in advanced maternal age: a key difference from younger pregnancies حسب Kazunari Nemoto (22495831)

"…In non-AMA pregnancies, serum sFlt-1 levels tended to be lower in PE cases compared to normotensive (NT) cases. Conversely, in AMA pregnancies, PE cases showed significantly higher serum sFlt-1 levels and sFlt-1/PlGF ratios than NT cases. …"

Table 1_Unpacking the cost implications of diagnosis-related groups reform for lumbar disc herniation patients in Chinese medicine: a closer look at evidence from China.xls حسب Meng-en Chen (22274533)

"…Objectives<p>Lumbar disc herniation (LDH) presents a significant economic burden globally, worsening in China due to an aging population. …"

Table 1_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.xlsx حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Image 2_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.jpeg حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Data Sheet 1_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.pdf حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Image 1_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.jpeg حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Image 3_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.jpeg حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Image 5_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.jpeg حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"

Image 4_Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database.jpeg حسب Zoltán Kiss (5570003)

"…Age-standardized 5-year net survival rates showed significant improvements from 2011-12 till 2017-19 periods for colorectal cancer from 55.08% to 59.78% (4.70%), lung cancer from 20.10% to 23.55% (3.45%), liver cancer from 11.21% to 16.97% (5.76%) and melanoma from 90.06% to 93.80% (3.73%), while clinically relevant, but not significant improvements for breast cancer from 85.03% to 86.84% (1.81%), prostate cancer from 88.13% to 89.76% (1.63%) and thyroid cancer from 87.23% to 92.36% (5.12%). …"